Metabolon, Inc. is the world's leading health technology company focused on the use of metabolomics in precision medicine. This powerful tool for assessing health is based on proprietary platforms and informatics that deliver biomarker discoveries, innovative diagnostic tests, and ground-breaking partnerships in genomics-based health initiatives. Metabolon's expertise is also accelerating research and product development across the pharmaceutical, biotechnology, consumer products, agriculture and nutrition industries, as well as academic and government organizations. Founded in 2000 and headquartered in Research Triangle Park, North Carolina, the company has conducted more than 5,000 independent and collaborative studies, resulting in over 600 peer-reviewed publications.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/08/16 | $15,000,000 |
Essex Woodlands | undisclosed | |
| 01/24/23 | $25,000,000 | Venture |
